Attitudes and Believes About Vaccinations in a Supportive Care Patient Population

To learn about the attitudes and beliefs towards vaccination both before and after the COVID-19 pandemic in patients who have received supportive care.

Study Overview

• Status: Active, not recruiting
• Conditions: Vaccinations
• Intervention / Treatment: Other: patient population

Detailed Description

Primary Objective:

Our primary objective is to assess patient perception of efficacy and safety of vaccinations.

Secondary Objectives:

To assess demographic predictors of those who would be considered as vaccine hesitant.

To assess patient preferred source of recommendations for or against vaccination.

To assess the role past side effects or allergic reactions play on patient perception of future vaccines.

To assess patient perception of vaccination prior to COVID-19.

To assess patient willingness to get the COVID-19 vaccine.

To assess patient willingness to get the influenza vaccine.

• Study Type: Observational
• Enrollment (Actual): 104

Contacts and Locations

• Study Contact: Name: Michael Tang, MD; Phone Number: (832) 468-8895; Email: mjtang@mdanderson.org

Study Locations

• United States
  • Texas
    • Houston, Texas, United States, 77030
      • M D Anderson Cancer Center
      • Contact: Michael Tang, MD; Phone Number: 832-468-8895; Email: mjtang@mdanderson.org
      • Principal Investigator: Michael Tang, MD

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No

• Sampling Method: Probability Sample

Study Population

M D Anderson Cancer Center

Description

Inclusion Criteria:

1. Patients who are seen as part of a clinic visit with the Supportive Care Clinic at M.D.

   Anderson Cancer Center, also patients who are being seen by the inpatient Supportive Medicine Consultation Service.

2. Patients who are 18 years of age or older
3. Patients who are able to speak English.

Exclusion Criteria:

1. Patients who are unable to sign written consent
2. Patients who are considered delirious at the time of the clinic encounter as defined by a Memorial Delirium Assessment Scale score of 7 or greater. The nursing staff, as a part of the patient intake process and routine care, performs the delirium assessment for clinic patients.

Study Plan

How is the study designed?

Design Details

• Observational Models: Other
• Time Perspectives: Cross-Sectional

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Supportive care patient population; Attitudes and Believes About Vaccinations, questionnaires	Other: patient population; questionnaires, standard of care

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Exploratory survey evaluating the solely patient's opinions and perceptions regarding the safety and efficacy of vaccinations for Parent Attitudes about Childhood Vaccines (PACV-4 scale) with a score of 2 or greater.	We will assess the patient's opinion and perception of the safety of vaccinations based upon a questionnaire and a Likert scale of responses.	through study completion, an average of 1 year

Collaborators and Investigators

• Sponsor: M.D. Anderson Cancer Center
• Investigators: Principal Investigator: Michael Tang, MD, M.D. Anderson Cancer Center

Publications and helpful links

Helpful Links

• M D Anderson Cancer Center

Study record dates

Study Major Dates

• Study Start (Actual): March 10, 2022
• Primary Completion (Estimated): February 1, 2026
• Study Completion (Estimated): February 1, 2026

Study Registration Dates

• First Submitted: March 8, 2022
• First Submitted That Met QC Criteria: April 7, 2022
• First Posted (Actual): April 15, 2022

Study Record Updates

• Last Update Posted (Estimated): April 30, 2024
• Last Update Submitted That Met QC Criteria: April 29, 2024
• Last Verified: April 1, 2024

More Information

Terms related to this study

• Other Study ID Numbers: 2021-1070; NCI-2022-00365 (Other Identifier: NCI-CTRP-Clinical Trial Reporting Registry)

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No